===============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
current report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of earliest event reported: January 29, 2003
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in charter)
Pennsylvania 1-8036 23-1210010
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
101 Gordon Drive, P.O. Box 645, Lionville, Pennsylvania 19341-0645
(Address of Principal Executive Offices) (Zip Code)
(610) 594-2900
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
===============================================================================
Item 5. Other Events.
On January 29, 2003, January 30, 2003 and February 4, 2003, West Pharmaceutical
Services, Inc. (the "Company") issued press releases relating to an incident on
January 29, 2003 at the Company's Kinston, North Carolina plant. The press
releases issued in connection with this incident are filed as exhibits 99.1,
99.2 and 99.3, respectively, to this report and are incorporated herein by
reference.
Item 7. Financial Statements, Pro Forma Financial Information and
Exhibits.
(c) Exhibits:
Exhibit # Description
99.1 Press Release dated January 29, 2003
99.2 Press Release dated January 30, 2003
99.3 Press Release dated February 4, 2003
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
WEST PHARMACEUTICAL SERVICES, INC.
Date: February 5, 2003 By: /s/ J.R. Gailey
------------------------
Name: John R. Gailey III
Title: Vice President
EXHIBIT INDEX
99.1 Press Release dated January 29, 2003
99.2 Press Release dated January 30, 2003
99.3 Press Release dated February 4, 2003